Company case study
Pranetics
Pranetics is a life sciences company specializing in DNA testing and COVID-19 testing kits. It came up on My First Million, hosted by Sam Parr and Shaan Puri, in the episode "How we scaled to $100M in under a year (ft. IM8 co-founder Danny Yeung)" (aired September 7, 2026).
At a glance
| Podcast | My First Million |
|---|---|
| Hosted by | Sam Parr and Shaan Puri |
| Episode | How we scaled to $100M in under a year (ft. IM8 co-founder Danny Yeung) |
| Aired | September 7, 2026 |
| Revenue and traction | Generated over 700 million in revenue over three years and had a peak valuation of 1 billion during the pandemic. |
| Category | E-commerce |
Figures and claims are as told on the episode, summarized from the transcript. Check the date: they describe the company at the time it aired.
What the episode said
How we scaled to $100M in under a year (ft. IM8 co-founder Danny Yeung) · aired September 7, 2026 · hosted by Sam Parr and Shaan Puri
Why it works
Pranetics capitalized on the COVID-19 pandemic by quickly developing a testing kit, becoming a leading provider in Hong Kong and the UK.
Founding story
Founded in 2014, Pranetics was initiated as a response to the emerging field of DNA testing and health diagnostics.
The playbook
Focused on rapid product development and positioning as a trusted COVID testing provider during the pandemic.
Also mentioned
Became a household name in Hong Kong, where mandatory testing was enforced for arriving travelers.
Why this works now (our analysis)
GDPR compliance has prompted increased demand for DNA testing and health diagnostics. Pranetics launched its first revenue-generating product, a COVID-19 testing kit, through partnerships with local health authorities in Hong Kong. The company faces a significant constraint in the form of regulatory hurdles associated with health testing approvals in various markets, which can delay product launches and increase costs.